a
a
Weather:
No weather information available
HomeHealthAuthor Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Nature Medicine, Published online: 21 July 2025; doi:10.1038/s41591-025-03894-2

Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

No comments

Sorry, the comment form is closed at this time.

Translate »